Total Immunoglobulin E (IgE)
Ige, Antigen, Antiserum, Control. 510(k) K220178, from Beckman Coulter, Inc. (Brea, CA). Product code DGC, class 2.
As of Nov 20, 2026, K220178 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Mar 23, 2022 after 61 days, with no recalls tied to it in FDA's recall database.
- Review time: 61 days
- Recalls: 0
The IgE assay is intended for use in the quantitative determination of Total Immunoglobulin E (IgE) concentration in human serum and plasma (lithium heparin, sodium heparin, K2-EDTA, K3-EDTA) on Beckman Coulter AU/DxC AU clinical chemistry analyzers. The determination aids in the diagnosis of IgE-mediated allergic disorders in conjunction with other clinical findings.
- Elecsys Ige Ii ImmunoassayK061970 · Roche Diagnostics · Aug 31, 2006
- Quantia IgEK214068 · Biokit, S.A. · Feb 21, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 21, 2022
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files